Extract

To assess the activity in terms of overall clinical benefit, defined as the objective response rate plus the rate of stable disease lasting longer than 24 weeks.

Inclusion criteria

• Pre-or post-menopausal women with histologically proven, locally advanced (inoperable) or metastatic breast cancer

Links

• ictrp
• euctr